Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 14/20 | 0.49 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | RAF1 | P04049 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PKLR | P30613 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24687640 | 0.92 | NPBWR1 (0.51) | NPBWR1MCHR1RAF1PKMPKLR | |
| SCHEMBL24687786 | 0.91 | NPBWR1 (0.46) | NPBWR1MCHR1RAF1PKMPKLR | |
| SCHEMBL29029933 | 0.90 | NPBWR1 (0.46) | NPBWR1MCHR1RAF1AKR1C3 | |
| SCHEMBL24467751 | 0.90 | NPBWR1 (0.46) | NPBWR1MCHR1RAF1AKR1C3 | |
| SCHEMBL21521227 | 0.88 | NPBWR1 (0.51) | NPBWR1MCHR1RAF1PKMPKLR | |
| SCHEMBL24640479 | 0.88 | NPBWR1 (0.51) | NPBWR1MCHR1RAF1PKMPKLR | |
| SCHEMBL21521225 | 0.88 | NPBWR1 (0.51) | NPBWR1MCHR1RAF1PKMPKLR | |
| SCHEMBL29029942 | 0.88 | NPBWR1 (0.44) | NPBWR1MCHR1RAF1AKR1C3 | |
| SCHEMBL24962320 | 0.87 | NPBWR1 (0.48) | NPBWR1MCHR1PKMPKLRBRD4 | |
| SCHEMBL24467802 | 0.87 | NPBWR1 (0.43) | NPBWR1MCHR1RAF1AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022242750-A1 | PIPERAZINE DERIVATIVE AND USE THEREOF IN MEDICINE | 成都百裕制药股份有限公司 | 2022-11-24 | — | — | WO | disclosed |